FDA posts menthol listening session

FDA posts menthol listening session

The Food and Drug Administration has posted transcripts and recordings of two listening sessions on its proposed menthol ban that were held in June, as a complement to comments submitted during the formal commenting process. Each session began with an FDA explanation of its proposed restrictions, after which members of the public were able to share their viewpoints. Read/hear the listening sessions.